Skip to main content

Table 1 Baseline characteristics of study subjects in 2018 (N = 151)

From: A pilot study on the validity and psychometric properties of the electronic EQ-5D-5L in routine clinical practice

 

Overall (N = 151)

GOPC (N = 101)

SOPC (N = 50)

P value†

Socio-Demographics (%, n)

    

Male

53.0 (80)

66.3 (67)

26.0 (13)

0.001

Female

47.0 (71)

33.7 (34)

74.0 (37)

 

Age (mean ± SD), year

64.77 ± 9.23 (151)

66.13 ± 8.42 (101)

61.52 ± 9.73 (50)

0.001

Education

   

0.154

Primary or less

45.0 (68)

52.5 (53)

30.0 (15)

 

Secondary

47.0 (71)

40.6 (41)

60.0 (30)

 

Tertiary

7.9 (12)

6.9 (7)

10.0 (5)

 

Diagnosis (%, n)

   

< 0.001

Back

35.1 (53)

16.8 (17)

72.0 (36)

 

Knee

58.3 (88)

78.2 (79)

18.0 (9)

 

Both

6.6 (10)

5.0 (5)

10.0 (5)

 

Duration of Diagnosis

   

0.001

< 1 year

15.2 (23)

17.8 (18)

10.0 (5)

 

1–< 5 years

45.0 (68)

32.7 (33)

70.0 (35)

 

5–10 years

17.9 (27)

17.8 (18)

18.0 (9)

 

> 10 years

21.9 (33)

31.7 (32)

2.0 (1)

 

Number of other Chronic Diseases

   

0.399

0

14.6 (22)

10.9 (11)

22.0 (11)

 

1–3

72.8 (110)

76.2 (77)

66.0 (33)

 

 > = 4

12.6 (19)

12.9 (13)

12.0 (6)

 

WOMAC (mean ± SD, n)

    

WOMAC Total score

27.69 ± 17.09 (149)

23.98 ± 16.07 (100)

35.92 ± 17.22 (50)

0.001

WOMAC Pain Subscale score

6.87 ± 4.06 (151)

6.11 ± 3.99 (101)

8.40 ± 3.81 (50)

0.001

WOMAC Stiffness Subscale score

2.48 ± 2.00 (150)

1.95 ± 1.84 (100)

3.54 ± 1.90 (50)

0.001

WOMAC Function Subscale score

18.45 ± 12.36 (150)

15.68 ± 11.18 (100)

23.98 ± 12.84 (50)

0.001

Pain Rating Scale scores (out of 10)

4.37 ± 2.35 (151)

3.94 ± 2.45 (101)

5.24 ± 1.90 (50)

0.001

EQ-5D-5L Dimensions Level % (n)

   

P value§

Mobility (% with Limitation)#

28.4

24.7

36.0

0.074

    No problems

25.2 (38)

26.7 (27)

22.0 (11)

 

    Slight problems

46.4 (70)

48.5 (49)

42.0 (21)

 

    Moderate problems

20.5 (31)

17.8 (18)

26.0 (13)

 

    Severe problems

7.9 (12)

6.9 (7)

10.0 (5)

 

    Extreme problems/unable to

0 (0)

0 (0)

0 (0)

 

Self-care (% with Limitation)#

7.3

6.9

8.0

0.403

    No problems

72.8 (110)

77.2 (78)

64.0 (32)

 

    Slight problems

19.9 (30)

15.8 (16)

28.0 (14)

 

    Moderate problems

6.6 (10)

6.9 (7)

6.0 (3)

 

    Severe problems

0.7 (1)

0 (0)

2.0 (1)

 

    Extreme problems/unable to

0 (0)

0 (0)

0 (0)

 

Usual activities (% with Limitation)#

21.9

10.9

44.0

< 0.001

    No problems

41.7 (63)

50.5 (51)

24.0 (12)

 

    Slight problems

36.4 (55)

38.6 (39)

32.0 (16)

 

    Moderate problems

17.2 (26)

6.9 (7)

38.0 (19)

 

    Severe problems

4.0 (6)

4.0 (4)

4.0 (2)

 

    Extreme problems/unable to

0.7 (1)

0 (0)

2.0 (1)

 

Pain (% with Limitation)#

47.7

40.6

62.0

0.007

    No problems

9.3 (14)

13.9 (14)

0 (0)

 

    Slight problems

43.0 (65)

45.5 (46)

38.0 (19)

 

    Moderate problems

35.1 (53)

30.7 (31)

44.0 (22)

 

    Severe problems

11.3 (17)

8.9 (9)

16.0 (8)

 

    Extreme problems/unable to

1.3 (2)

1.0 (1)

2.0 (1)

 

Anxiety/depression (% with Limitation)#

15.9

9.9

28.0

0.002

    No problems

51.0 (77)

60.4 (61)

32.0 (16)

 

    Slight problems

33.1 (50)

29.7 (30)

40.0 (20)

 

    Moderate problems

11.3 (17)

7.9 (8)

18.0 (9)

 

    Severe problems

3.3 (5)

2.0 (2)

6.0 (3)

 

    Extreme problems/unable to

1.3 (2)

0 (0)

4.0 (2)

 

EQ-5D-5L Utility score (mean ± S.D.)

0.62 ± 0.26

0.67 ± 0.23

0.52 ± 0.27

0.001

EQ-VAS score (mean ± S.D.)

67.89 ± 17.09

71.3 ± 15.78

61.06 ± 17.75

 < 0.001

  1. GOPC = general outpatient clinic; SOPC = specialist outpatient clinic; WOMAC = Western Ontario and McMaster University Osteoarthritis Index
  2. #EQ-5D-5L dimension responses of moderate, severe and very severe were grouped into the “with Limitation” category
  3. Tested by independent t-test; § tested by Chi-square test